Bigelow Investment Advisors LLC Sells 90 Shares of The Clorox Company (NYSE:CLX)

Bigelow Investment Advisors LLC decreased its position in The Clorox Company (NYSE:CLXFree Report) by 4.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,923 shares of the company’s stock after selling 90 shares during the quarter. Bigelow Investment Advisors LLC’s holdings in Clorox were worth $274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of CLX. Norges Bank bought a new stake in Clorox in the 4th quarter worth approximately $101,609,000. Imprint Wealth LLC increased its stake in Clorox by 16,986.8% in the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock worth $55,139,000 after purchasing an additional 548,165 shares during the period. Qube Research & Technologies Ltd increased its stake in Clorox by 75.9% in the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after purchasing an additional 487,974 shares during the period. International Assets Investment Management LLC increased its stake in Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after purchasing an additional 481,725 shares during the period. Finally, Acadian Asset Management LLC increased its stake in Clorox by 39.6% in the 3rd quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock worth $192,319,000 after purchasing an additional 415,999 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CLX shares. Deutsche Bank Aktiengesellschaft reduced their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday. Morgan Stanley reissued an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. UBS Group boosted their target price on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, February 2nd. Barclays reduced their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 10th. Finally, The Goldman Sachs Group started coverage on Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price target on the stock. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $148.63.

Get Our Latest Report on Clorox

Clorox Trading Up 0.3 %

Shares of NYSE:CLX opened at $143.58 on Friday. The stock has a market capitalization of $17.82 billion, a price-to-earnings ratio of 227.91, a PEG ratio of 2.26 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The stock’s 50-day simple moving average is $149.99 and its two-hundred day simple moving average is $141.79. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter last year, the company earned $0.98 earnings per share. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. Analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 761.92%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.